Rating History for Intra-Cellular Therapies (ITCI) by Canaccord

More Stocks Rated by Canaccord | Latest Ratings for ITCI
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
2/28/2025 Sumant Kulkarni Upgrade Buy
(Hold)		 132.00
(N/A)		 128.25
(131.87)		 2.82% Details